

Insulin pump/blood glucose sensor: Sensor readings can be affected and result in overdosing of insulin related to incorrect high glucose readings as a precaution, users should be vigilant of any erratic or incorrect (high or low) glucose level(s) or insulin dosing events

Of note, Baxter is informing users of the following potential hazards, though additional devices may be affected: There is insufficient data about distance on the remaining two reported interferences. To date, interference in all cases but two is known to have occurred at distances less than one meter. Baxter is also issuing an updated customer notification letter for this correction, replacing the previous letter issued on September 30, 2022. This product is manufactured by Hillrom, which was acquired by Baxter in late 2021. Depending on the intended use of the device that malfunctions, there may be different hazardous situations that could occur. This RF interference could result in erroneous readings or additional malfunctions of these other devices and could therefore result in inappropriate medical intervention. Although the WatchCare system has been developed to comply with the most recent RF standards, it radiates RF that might affect other devices in the vicinity, including devices on both patients and staff members. The WatchCare system is designed to discreetly alert the caregiver of an incontinence event. K product number P00697902 WatchCare System for Progressa Bed product number P00697903 and WatchCare System for Centrella Bed product number P00697905. A-J product number P00697901 WatchCare System for VersaCare Bed Rev. See More Centrella Bed with WatchCare product number P7900B WatchCare System for VersaCare Bed Rev. This Urgent Medical Device Correction applies to. The WatchCare System is distributed in the United States. announced today it has issued an Urgent Medical Device Correction for the WatchCare Incontinence Management System due to potential for radio frequency (RF) interference with other medical devices.
